Correlation of (18)F-BPA and (18)F-FDG uptake in head and neck cancers

Hitomi Tani,Hiroaki Kurihara,Kenta Hiroi,Natsuki Honda,Mitsuyoshi Yoshimoto,Yuzuru Kono,Ryusuke Murakami,Shinichiro Kumita,Yasuaki Arai,Jun Itami
DOI: https://doi.org/10.1016/j.radonc.2014.11.001
Abstract:Background and purpose: The aim of this study was to compare the accumulation of 4-borono-2-(18)F-fluoro-phenylalanine ((18)F-BPA) with that of (18)F-fluorodeoxyglucose ((18)F-FDG) in head and neck cancers, and to assess the usefulness of (18)F-FDG PET for screening candidates for boron neutron capture therapy (BNCT). Material and methods: Twenty patients with pathologically proven malignant tumors of the head and neck were recruited from March 2012 to January 2014. All patients underwent both whole-body (18)F-BPA PET/CT and (18)F-FDG PET/CT within 2weeks of each other. The uptakes of (18)F-BPA and (18)F-FDG at 1h after injection were evaluated using the maximum standardized uptake value (SUVmax). Results: The accumulation of (18)F-FDG was significantly correlated with that of (18)F-BPA. The SUVmax of (18)F-FDG ⩾5.0 is considered to be suggestive of high (18)F-BPA accumulation. Conclusions: (18)F-FDG PET might be an effective screening method performed prior to (18)F-BPA for selecting patients with head and neck cancer for treatment with BNCT.
What problem does this paper attempt to address?